Sunday, November 24, 2024

Global leaders unite for World Evidence-Based Healthcare Day

Seven global leaders in evidence-based healthcare, including the University of Adelaide’s JBI, have joined forces to raise awareness for better evidence to inform healthcare policy...

Covid inquiry evidence from Newcastle University expert

A world-leading expert on health inequalities has presented a report and evidence to the independent public inquiry into the Covid pandemic.

Socio-economic, environmental impacts of coronavirus quantified

How is COVID-19 impacting people and the planet and what are the implications for a post-pandemic world? This world-first study led by the University of Sydney quantifies the socio-economic losses and environmental gains.

COVID economic concerns mean all that glitters really is gold now

With prices for the precious metal close to record highs in world markets, gold has outstripped other investments and investor enthusiasm appears endless.

HKU scientists and microbiologists jointly discover a novel antiviral strategy for treatment of COVID-19...

A research team led by Professor Hongzhe SUN, Norman & Cecilia Yip Professor in Bioinorganic Chemistry, Department of Chemistry...

Study finds “high level” of COVID vaccine resistance

Almost three-in-five Australians (58.5 per cent) say they will definitely get a COVID vaccine once it is available, new analysis from The Australian National University (ANU) shows.

Highlights from Development Day 2020: The impact of the COVID-19 pandemic in Eastern Europe

After having been relatively mildly affected in the first wave, Eastern Europe is currently in the midst of the second wave of the COVID-19 pandemic with much higher levels of infected and dead compared to the spring.

Viruses can ‘hijack’ cellular process to block immune response

Research led by McGill University and Queen’s University Belfast has found that viruses can ‘hijack’ an existing molecular process in the cell in order to block the body’s antiviral immune response to a viral infection.

USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly...

A Phase III study of the Oxford-AstraZeneca coronavirus vaccine conducted by AstraZeneca plc in the USA, Chile and Peru has shown that vaccine is safe and highly effective...

HKBU business survey reveals the importance of customer appreciation amid the COVID-19 pandemic

On 29th April, HKBU’s Department of Marketing partnered with the Hong Kong Association for Customer Service Excellence (HKACE) to announce the survey results...
- Advertisement -